Origami Surgical announced today that it received FDA clearance for the insertion and removal of its StitchKit device. Madison, New Jersey-based Origami’s new FDA indication allows for insertion or removal through any existing 8mm trocar incision while the surgeon watches the action via the laparoscope. This allows for StitchKit use even with no 12mm trocars […]
Origami Surgical
Origami Surgical gains FDA clearance for robotic suturing devices
Origami Surgical today announced that the FDA has granted 510(k) clearance for three new types of sutures for its StitchKit robotic surgery platform. The company describes StitchKit as a patented suture delivery and retrieval system designed so sutures are efficiently inserted and needles are safely removed from the surgical field. StitchKit also allows the robotic […]
FDA clears Origami Surgical suture-delivery device
Origami Surgical announced that the FDA has cleared StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice. The StitchKit PARK cartridge allows the surgeon to pre-load the desired sutures for any procedure. Once loaded with needles and sutures, the device is closed and […]
Origami Surgical raises $2.2m for robotic suturing tech
Origami Surgical last week filed an SEC Form D to confirm the sale of more than $2.2 million in an equity offering. The Madison, N.J.-based company, founded this year, filed a new notice for the sale of equity on March 23, 2020, with the intention of the offering lasting less than a year. According to […]